How AI and analytics can automate CMS coding for physicians

One year into COVID-19, physicians are still stretched thin, especially with stringent Centers for Medicare and Medicaid Services coding requirements that burden already overworked healthcare providers. But analytics programs, especially combined with artificial intelligence, can help by automating coding and quality reporting, while alleviating clinician burnout and reducing errors. Healthcare IT News interviewed Mark Halford, senior vice

Scientists launch clinical trial of CRISPR gene correction therapy in patients with sickle cell disease

Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient's own blood-forming stem cells. The trial will combine CRISPR technology developed at Innovative Genomics

Long covid: Shocking 1.1million record having ‘long covid’ symptoms

Dr Hilary outlines 'worry' for rise in coronavirus infections When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time. The Office

Poor judgment of autistic adults

Autistic adults can be wrongly perceived as deceptive and lacking credibility, Flinders University researchers say, with this working against many caught in the legal system. Ahead of World Autism Awareness Day (2 April 2021), a new paper in the Journal of Autism and Developmental Disorders asked 1,410 civilians to respond to video recordings with 30

Roche's Evrysdi wins EU approval for spinal muscular atrophy

FILE PHOTO: A sign at a diagnostics site for Swiss pharmaceutical giant Roche is seen, in Burgess Hill, Britain, October 7, 2020. REUTERS/Peter NichollsZURICH (Reuters) – Roche’s Evrysdi has won approval from the European Commission as the first and only at-home treatment for spinal muscular atrophy (SMA), the Swiss drugmaker said on Tuesday. It has

Pfizer-BioNTech vaccine causes steep drop in COVID-19 among healthcare workers

A team of scientists from Spain has recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine developed by Pfizer-BioNTech (BNT162b2).  Their findings reveal that a 2-dose regimen of BNT162b2 vaccine is capable of providing almost 100% protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in healthcare workers. The study is

Check All Components in Cases of Suspected Shoe Allergy

Approximately 20% of shoe allergens are not detected with the current screening series, according to a retrospective study of more than 30,000 patients. Contact allergy to shoes remains a common but difficult problem for many reasons, including the limited information from shoe manufacturers, differences in shoe manufacturing processes, and changes in shoe trends, said Raina

The third generation of siRNA delivery system makes RNAi therapy feasible

In a new study published in the Cell Research, Chen-Yu Zhang’s group at Nanjing University reports “In vivo self-assembled small RNA is the new generation of RNAi therapeutics.” The development of RNAi therapy has undergone two major stages, direct injection of synthetic siRNAs and delivery with artificial vehicles; neither have realized the full therapeutic potential

Even in a pandemic, child vision tests are crucial

It’s critical for parents to maintain their children’s vision checkups during the COVID-19 pandemic, an expert says. “All children should have their eyes checked by their pediatrician at regular intervals, even if they don’t have any symptoms,” said Dr. Samantha Feldman, a pediatric ophthalmologist at the Krieger Eye Institute in Baltimore. “Part of the reason

Inactivity Drives 1 in 14 Deaths Globally, New Data Suggest

The high cost of a sedentary lifestyle just became a bit more evident ― a new global study shows that inactivity drives up to 8% of noncommunicable diseases and mortality. Physical inactivity, defined as engaging in less than 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity physical activity per week, caused 7.2% (95% CI,